UNICA IRIS Institutional Research Information System

LOREFICE, LORENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 229.417
NA - Nord America 7.622
AS - Asia 3.401
SA - Sud America 433
AF - Africa 75
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 9
Totale 240.970
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 227.156
US - Stati Uniti d'America 7.514
CN - Cina 1.292
SG - Singapore 1.289
SE - Svezia 488
UA - Ucraina 454
DE - Germania 350
BR - Brasile 323
VN - Vietnam 285
FI - Finlandia 255
GB - Regno Unito 240
FR - Francia 197
HK - Hong Kong 96
IN - India 88
NL - Olanda 70
CA - Canada 66
KR - Corea 56
AR - Argentina 36
BD - Bangladesh 35
TR - Turchia 34
ES - Italia 29
RU - Federazione Russa 28
IQ - Iraq 27
JP - Giappone 26
MX - Messico 26
ZA - Sudafrica 25
CZ - Repubblica Ceca 23
EC - Ecuador 23
PL - Polonia 22
IR - Iran 18
AT - Austria 17
MA - Marocco 17
BE - Belgio 15
PK - Pakistan 15
LT - Lituania 14
UZ - Uzbekistan 14
CL - Cile 13
EU - Europa 13
SA - Arabia Saudita 13
PH - Filippine 12
ID - Indonesia 11
CO - Colombia 10
MY - Malesia 10
VE - Venezuela 10
AZ - Azerbaigian 9
IL - Israele 9
AE - Emirati Arabi Uniti 8
AU - Australia 8
EG - Egitto 8
PS - Palestinian Territory 8
RO - Romania 8
JO - Giordania 7
KE - Kenya 7
TH - Thailandia 7
UY - Uruguay 7
DK - Danimarca 6
GR - Grecia 6
IE - Irlanda 6
HU - Ungheria 5
NP - Nepal 5
PY - Paraguay 5
CH - Svizzera 4
CR - Costa Rica 4
DZ - Algeria 4
LB - Libano 4
MD - Moldavia 4
TN - Tunisia 4
DO - Repubblica Dominicana 3
ET - Etiopia 3
HR - Croazia 3
KW - Kuwait 3
KZ - Kazakistan 3
OM - Oman 3
PE - Perù 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
TW - Taiwan 3
AL - Albania 2
BG - Bulgaria 2
BO - Bolivia 2
CI - Costa d'Avorio 2
GE - Georgia 2
KG - Kirghizistan 2
NO - Norvegia 2
PA - Panama 2
PR - Porto Rico 2
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BT - Bhutan 1
CG - Congo 1
CY - Cipro 1
EE - Estonia 1
GT - Guatemala 1
GY - Guiana 1
JM - Giamaica 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
Totale 240.962
Salva come PNG Salva come JPEG
Città #
Cagliari 222.288
Uta 4.082
Ashburn 867
Fairfield 669
Singapore 652
Woodbridge 509
Chandler 440
San Jose 390
Dallas 387
Houston 364
Wilmington 324
Ann Arbor 290
Nyköping 277
Boardman 276
Seattle 266
Beijing 239
Cambridge 212
Jacksonville 201
Helsinki 168
Dearborn 154
New York 140
Los Angeles 136
Munich 115
Santa Clara 115
Nanjing 111
Shanghai 104
The Dalles 100
Lauterbourg 93
Ho Chi Minh City 86
Milan 83
Boston 82
Hong Kong 82
Hefei 64
Hanoi 56
Seoul 55
Buffalo 48
Council Bluffs 46
Nanchang 42
Rome 39
Washington 39
Norwalk 38
Orem 37
São Paulo 37
Guangzhou 36
Redwood City 36
Sassari 36
Shenyang 35
Atlanta 32
Hebei 32
London 30
San Diego 29
Chicago 28
Jiaxing 28
Toronto 27
Frankfurt am Main 26
Hangzhou 26
Tokyo 24
Phoenix 23
Stockholm 23
Verona 23
Tianjin 22
Changsha 21
Amsterdam 20
Dong Ket 20
Chennai 19
Da Nang 19
Warsaw 19
Brooklyn 17
Montreal 17
Jinan 16
Brno 15
Denver 15
Düsseldorf 15
Johannesburg 15
Redondo Beach 15
Florence 14
Turku 14
Columbus 13
Manchester 13
Mexico City 13
Shenzhen 13
Taizhou 13
Kunming 12
Naples 12
Nuremberg 12
Zhengzhou 12
Paris 11
Poplar 11
Tashkent 11
Curitiba 10
Domusnovas 10
Mountain View 10
Mumbai 10
New Delhi 10
Ningbo 10
Wuhan 10
Baku 9
City of London 9
Haiphong 9
Rio de Janeiro 9
Totale 235.842
Salva come PNG Salva come JPEG
Nome #
(1)H-NMR analysis provides a metabolomic profile of patients with multiple sclerosis 5.967
Vitamin D responsive elements within the HLA-DRB1 promoter region in Sardinian multiple sclerosis associated alleles 5.238
Erratum to: Charcot–Marie–Tooth disease: genetic subtypes in the Sardinian population (Neurological Sciences, (2017), 38, 6, (1019-1025), 10.1007/s10072-017-2905-x 4.936
Evaluation of Stroop color word test as cognitive task to investigate cognitive motor interference during walking in Multiple Sclerosis 4.576
Quantitative assessment of alterations induced by spasticity on gait of individuals with multiple sclerosis using 3D gait analysis 4.484
Is Geo-Environmental Exposure a Risk Factor for Multiple Sclerosis? A Population-Based Cross-Sectional Study in South-Western Sardinia 4.390
Role of interferon-beta in Mycobacterium avium subspecies paratuberculosis antibody response in Sardinian MS patients 4.299
The burden of multiple sclerosis variants in continental Italians and Sardinians 4.216
Overexpression of the cytokine BAFF and autoimmunity risk 4.105
Intrathecal oligoclonal bands synthesis in multiple sclerosis: is it always a prognostic factor? 4.036
Assessment of geochemical factors in multiple sclerosis distribution in the South-Western Sardinia 4.009
Mycobacterium avium subsp. Paratuberculosis and multiple sclerosis in Sardinian patients: Epidemiology and clinical features 3.924
What do multiple sclerosis patients and their caregivers perceive as unmet needs? 3.880
Exploring cognitive motor interference in multiple sclerosis by the visual Stroop test 3.837
Clinical Assessment of Gait in Individuals with Multiple Sclerosis Using Wearable Inertial Sensors: Comparison with Patient-Based Measure 3.836
Interaction between HLA-DRB1-DQB1 haplotypes in Sardinian multiple sclerosis population 3.814
Fatigue, as measured using the Modified Fatigue Impact Scale, is a predictor of processing speed improvement induced by exercise in patients with multiple sclerosis: data from a randomized controlled trial 3.731
Performance in daily activities, cognitive impairment and perception in multiple sclerosis patients and their caregivers 3.661
Walking improvements with nabiximols in patients with multiple sclerosis 3.648
Localized pigmentation disorder after subcutaneous pegylated interferon beta-1a injection 3.616
Quantifying gait impairment in individuals affected by Charcot-Marie-Tooth disease: the usefulness of gait profile score and gait variable score 3.608
Multiple sclerosis and HLA genotypes: A possible influence on brain atrophy 3.586
Factors influencing MS outcome in Sardinia: a clinical and genetic study 3.584
A genetic association study of two genes linked to neurodegeneration in a Sardinian multiple sclerosis population: The TARDBP Ala382Thr mutation and C9orf72 expansion 3.506
The impact of modifiable risk factors on lesion burden in patients with early multiple sclerosis 3.433
Impact of brain atrophy on walking in multiple sclerosis patients with low disability: a dual task study. 3.405
Impact of the media on future hope in multiple sclerosis 3.382
Long-term follow-up more than 10 years after HSCT: a monocentric experience 3.313
Association between brain atrophy and cognitive motor interference in multiple sclerosis 3.305
Multiple Sclerosis and environmental factors. 3.291
Are static and functional balance abilities related in individuals with Multiple Sclerosis? 3.288
Oral agents in multiple sclerosis 3.209
Influence of treatments in multiple sclerosis disability: a cohort study 3.178
‘Timed up and go’ and brain atrophy: a preliminary MRI study to assess functional mobility performance in multiple sclerosis 3.163
Top-down proteomic profiling of human saliva in multiple sclerosis patients 3.137
A genetic study of the FMR1 gene in a Sardinian multiple sclerosis population 3.110
Metabolomic analysis identifies altered metabolic pathways in Multiple Sclerosis 3.100
An unusual infection in MS patient treated with dimethyl fumarate: A case report of omphalitis 3.055
Brain volume in early MS patients with and without IgG oligoclonal bands in CSF 3.040
Smoothness of gait, but not spatio-temporal parameters, are altered in early stages of Multiple Sclerosis 2.991
Refining the connection between gait and cognition: training the body to improve the brain 2.981
Is There Any Relationship between Upper and Lower Limb Impairments in People with Multiple Sclerosis? A Kinematic Quantitative Analysis 2.978
Charcot–Marie–Tooth disease: genetic subtypes in the Sardinian population 2.975
Multiple sclerosis risk: interaction between human leukocyte antigen and the environment in Sardinian population 2.874
Cognition in multiple sclerosis: Between cognitive reserve and brain volume 2.871
Hourly trends of physical activity in people with Multiple Sclerosis 2.849
Postural adaptation during a Nintendo Wii balance training 2.668
Perception of risk and shared decision making process in multiple sclerosis 2.652
Are static and dynamic balance abilities correlated in people with Multiple Sclerosis? 2.593
Pregnancy outcome in multiple sclerosis women treated with mitoxantrone 2.556
Vitamin D serum levels and balance are not related in Multiple Sclerosis 2.443
Evaluation of high doses of ascorbic acid efficacy in Charcot Marie Tooth type 1A 2.331
Attitude towards physical activity in patients with multiple sclerosis: a cohort study 2.326
The cohort of the multiple sclerosis center of Cagliari 2.321
Induction and escalation therapies in multiple sclerosis 2.279
Presence of oligoclonal IgG bands in Sardinians with multiple sclerosis is influenced by carriage of different HLA DRB1-DQB1 haplotypes 2.256
Thyroid antibodies in the CSF of Sardinian multiple sclerosis patients 2.225
Multiple sclerosis and fertilization in vitro with embryo transfer (FIVET): a case report 2.068
Validation of the DYMUS questionnaire for the assessment of dysphagia in multiple sclerosis 1.957
Epidemiology of multiple sclerosis in south-western Sardinia 1.925
The risk of bipolar disorders in multiple sclerosis 1.876
The impact of deep grey matter volume on cognition in Multiple Sclerosis 1.813
Coenzyme Q10 in the cerebrospinal fluid of multiple sclerosis patients 1.807
Long-term follow-up of pediatric MS patients starting treatment with injectable first-line agents: A multicentre, Italian, retrospective, observational study 1.775
Evaluation of FMR1 gene premutation in Sardinians multiple sclerosis 1.748
Facial synkinesis as a first symptom of multiple sclerosis 1.748
Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone 1.698
Occurence of autoimmune diseases in Sardinian multiple sclerosis patients and in their first degree relatives 1.645
Characterization of gait abnormalities in individuals affected by multiple sclerosis by means of the Gait Profile Score 1.639
Monoclonal antibodies: a target therapy for multiple sclerosis 1.478
Relationship between HLA DRB1-DQB1 haplotypes and oligoclonal IgG bands in Sardinians MS patients 1.403
Multiple sclerosis and bipolar disorders: the burden of comorbidity and its consequences on quality of life 1.393
Prevalence of patient-reported dysphagia in multiple sclerosis patients: an Italian multicenter study (using the DYMUS questionnaire). 1.390
Autoimmune diseases in Sardinian multiple sclerosis patients and in their first degree relatives 1.351
Delayed effect of age at onset on disability progression in multiple sclerosis 1.302
Coenzyme Q10 in the CSF of MS patients 1.137
Q10 in the CSF of MS patients 1.124
Gait initiation evaluation in multiple sclerosis 1.100
Postural sway analysis as tool to assess balance impairments in individuals with multiple sclerosis 1.057
Brain-reactive autoantibodies in neuropsychiatric systemic lupus erythematosus 1.044
1H-NMR-Based Metabolomics in Autism Spectrum Disorder and Pediatric Acute-Onset Neuropsychiatric Syndrome 1.038
Effects of Pregnancy and Breastfeeding on Clinical Outcomes and MRI Measurements of Women with Multiple Sclerosis: An Exploratory Real-World Cohort Study 1.031
Epidemiology of multiple sclerosis in south western Sardinia: nature versus nurture 1.026
Optic Neuritis: a common MS symptom or a peculiar phenotype? 1.013
Sex Hormones as Key Modulators of the Immune Response in Multiple Sclerosis: A Review 921
Mitoxantrone treatment in patients with early relapsing-remitting multiple sclerosis 920
Optic Neuritis: a common MS symptom or a specific phenotype? 852
Event-related potentials and deep grey matter atrophy in multiple sclerosis: Exploring the possible associations with cognition 796
null 756
Leukocyte telomere length in women with multiple sclerosis: Comparison with healthy women during pregnancy and puerperium 729
Impact of Menopause in Patients with Multiple Sclerosis: Current Perspectives 727
Evolution of teriflunomide use in multiple sclerosis: A real-world experience 643
The impact of the secondary infections in ICU patients affected by COVID-19 during three different phases of the SARS-CoV-2 pandemic 604
Omics approaches to understanding the efficacy and safety of disease-modifying treatments in multiple sclerosis 390
Role of geo-chemical environmental factors in multiple sclerosis distribution in the south-western Sardinia 291
Evaluation of the Metabolomics Profile in Charcot–Marie–Tooth (CMT) Patients: Novel Potential Biomarkers 92
Totale 241.372
Salva come PNG Salva come JPEG
Categoria #
all - tutte 280.027
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 280.027
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20219.393 0 0 0 0 0 0 0 0 0 3.724 3.563 2.106
2021/202210.954 1.592 696 461 995 913 567 508 535 1.181 1.097 1.293 1.116
2022/202314.125 1.393 2.254 2.025 1.159 1.054 1.359 558 1.092 741 789 1.071 630
2023/202414.464 910 926 682 1.154 1.391 2.454 1.392 1.408 686 964 1.233 1.264
2024/202540.889 13.972 13.782 4.243 2.514 1.416 1.628 2.067 166 294 298 231 278
2025/20266.487 603 356 692 659 620 521 1.228 700 402 706 0 0
Totale 241.372